New Global Alliance To Drive Momentum On Decentralized Trials
The Coronavirus Pandemic Is Forcing A Shift In Attitude
A new multi-stakeholder alliance wants to improve the adoption of decentralized clinical trials that have already drawn much attention during the COVID-19 pandemic. There are plans to aggregate best practices, share evidence and information, and identify and address key barriers.